Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook


 


 

Protection against dementia may run in families

20 August 2012

By Dr Sophie Pryor

Appeared in BioNews 669

Families with higher levels of a protein linked to inflammation may be at a reduced risk of dementia.

Scientists at the Mount Sinai School of Medicine in New York, USA, tested elderly men without dementia for levels of a substance called C-reactive protein (CRP) and found that those with higher levels were 30 percent less likely to have relatives with dementia.

They also found that the amount of CRP was associated with greater memory quality. 'Those who were doing best in memory function and cognition were the ones with the highest levels of CRP', said study author Dr Jeremy Silverman.

The study involved 277 dementia-free men, aged 75 and over. The researchers interviewed their parents and siblings and found that, of the 1,329 relatives questioned, 40 people from 37 families had dementia. A second, independent group of 51 men was also included, with nine of their 202 relatives found to have the condition.

While CRP has been previously associated with impaired cognition in younger people, the authors suggested that a high amount of the protein in older, dementia-free adults could indicate the presence of other protective factors.

'It's not necessarily that a high level of CRP, which is a bad thing, suddenly becomes a good thing in late age', Dr Silverman explained. 'It's more likely that these people are carrying protection against these bad elements'.

On its website, the Alzheimer's Society pointed out that CRP is actually more likely to be a 'risk factor rather than protection against dementia'. However, it said: 'This interesting research suggests that people who do not develop dementia despite potentially being more at risk might share genetic or lifestyle factors with their families that make them less likely to develop the condition'.

The protective elements are yet to be identified. But it is hoped that by using CRP levels to identify those who are resistant to dementia scientists will then be able to find genes associated with cognition and memory. Dr Silverman hopes that such discoveries will ultimately help develop treatments, or even cures, for dementia and Alzheimer's disease.

'The value of identifying genes is not to pick out the people who are protected, but rather it allows us to understand the mechanisms involved and lead to preventative methods to protect against dementia for those who don't carry the genes', he said.

The study was published in the journal Neurology.

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

01 December 2014 - by Chris Hardy 
Common variants of immune-related genes have been linked with memory performance...
02 September 2013 - by Michelle Downes 
Age-related memory loss could be the result of low levels of protein in the brain, according to researchers at Columbia University Medical Center (CUMC)...
19 November 2012 - by Helen Brooks 
A single genetic mutation increases the risk of developing Alzheimer’s disease by threefold, say scientists from two independent research groups...

16 July 2012 - by Dr Linda Wijlaars 
A rare genetic mutation, found in about one percent of Icelanders in a recent study, appears to protect against Alzheimer's disease and age-related cognitive decline. It is the first mutation found to act in this way and could be a target for future drug therapy...
18 June 2012 - by Dr Linda Wijlaars 
A gene known to be found in many Alzheimer's patients has been linked to the way insulin is processed in the body. The finding could prove there is a link between Alzheimer's disease and type 2 diabetes, explaining why people with diabetes face a higher risk of developing Alzheimer's....
05 March 2012 - by Maria Botcharova 
An enzyme associated with memory loss can be blocked to reverse symptoms of Alzheimer's disease in mice, a study has shown...
20 February 2012 - by Dr Caroline Hirst 
Skin cells from volunteers with Down's syndrome have been turned into brain cells in order to provide a new model for researchers to study Alzheimer's disease...
26 September 2011 - by George Frodsham 
Researchers have identified a strong link between a genetic fault and two common neurological disorders. Two independent studies have found that the mutation is common in patients with amyotrophic lateral sclerosis (ALS) and patients with frontotemporal dementia (FTD), particularly if the disease is familial...

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Andy Greenfield

Dr Anna Smajdor

Dr Henry Malter

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross

Sandy Starr


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation